Changes in erythromycin pharmacokinetics induced by renal failure. 1987

A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry

As erythromycin ototoxicity appears to be favored by renal insufficiency, its pharmacokinetics were assessed in chronic uremic patients treated by maintenance hemodialysis in comparison with normal subjects. Two groups of 8 patients each were studied, the first one on an interdialytic day, the second immediately after the end of an hemodialysis session. All subjects ingested a single dose of 1 gram of erythromycin ethylsuccinate. Times of peak serum concentration and biological half-lifes were similar in patients and in controls. Maximum serum concentrations and areas under the serum concentration time-curve were higher in patients than in controls whereas apparent oral clearances were lower in the former. The differences between the two groups of patients were not significant. These pharmacokinetic changes are suggestive of an enhanced bioavailability of erythromycin in chronic renal failure which might predispose uremics to the ototoxicity of the drug.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D004917 Erythromycin A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. Erycette,Erymax,Erythromycin A,Erythromycin C,Erythromycin Lactate,Erythromycin Phosphate,Ilotycin,T-Stat,Lactate, Erythromycin,Phosphate, Erythromycin,T Stat,TStat
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006311 Hearing Disorders Conditions that impair the transmission of auditory impulses and information from the level of the ear to the temporal cortices, including the sensorineural pathways. Distorted Hearing,Dysacusis,Paracousis,Paracusis,Hearing Disorder,Hearing, Distorted
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses

Related Publications

A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry
July 1984, American journal of kidney diseases : the official journal of the National Kidney Foundation,
A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry
August 1977, British medical journal,
A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry
April 1998, Neurogastroenterology and motility,
A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry
November 1983, Anaesthesia and intensive care,
A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry
September 2004, Biopharmaceutics & drug disposition,
A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry
February 1987, Antimicrobial agents and chemotherapy,
A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry
March 1987, Anesthesiology,
A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry
September 1983, British journal of clinical pharmacology,
A Kanfer, and G Stamatakis, and J C Torlotin, and G Fredj, and S Kenouch, and J P Méry
January 2011, Drug metabolism and pharmacokinetics,
Copied contents to your clipboard!